Last reviewed · How we verify
NCT06055972
Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health
NA trial testing Educational Letter Post CT Examination in Coronary Artery Disease in 800 participants. Participants enrolled and being followed up; not accepting new ones.
30 January 2025
Quick facts
| Lead sponsor | American College of Radiology |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 800 |
| Start date | 19 December 2023 |
| Primary completion | 30 January 2025 |
| Estimated completion | 2 February 2025 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Educational Letter Post CT Examination
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Smoking — all drugs for Smoking →
Sponsor
American College of Radiology
Who can join
Adults 50 to 80, any sex, with Coronary Artery Disease or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This multicenter clustered randomized prospective study will be managed by the American College of Radiology Center for Research and Innovation (ACR CRI). The research team aims to test the efficacy of a patient-centered educational intervention based on coronary artery calcification (CAC) information in cardiovascular risk factor modification of a cohort of patients enrolled in lung cancer screening (LCS) programs across the country.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06055972
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other American College of Radiology trials
Trials by the same sponsor.
- NCT05625659 — Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts · NA · recruiting
- NCT04426539 — New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study · completed
- NCT00794339 — Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer · Phase 2 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06055972 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by American College of Radiology
- Last refreshed: 6 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06055972.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing